Publication | Open Access

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

VaccinationCancer-associated VirusVaccine DevelopmentCervical CancerHuman Papillomavirus VaccinesVaccine TargetImmunologyHpv16 Peptide VaccinationGynecologyTherapeutic VaccineUterine CervixLong-term Immune ResponsePublic HealthMedicinePrecancerous LesionsCervical Cancer Prevention